Documented risk-based antithrombotic management and 30-day outcomes after endoscopic hemostasis for non-variceal upper gastrointestinal bleeding: a retrospective cohort study
Objective To evaluate whether documented adherence to a prespecified risk-based antithrombotic management framework was associated with 30-day rebleeding, thromboembolism, and net adverse clinical events (NACE) after therapeutic endoscopy for non-variceal upper gastrointestinal bleeding (NVUGIB). Methods This single-ce...